FDA Seeks Comment on BPD, HCT/P Deviation Reporting
February 25, 2026
FDA Issues Draft Guidance Establishing Framework for Individualized Gene Therapies
February 25, 2026
Japanese Regulatory Panel Recommends Advancing World’s First iPSC-Based Therapies
February 24, 2026